Morfex (Flurazepam Hydrochloride)

Flurazepam, the active ingredient in Morfex, is a benzodiazepine presented as an oral tablet for oral use. It acts as a sedative‑hypnotic and is prescribed primarily for the short‑term management of insomnia in adult patients who experience difficulty falling or staying asleep.

GNH USA supplies Morfex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product availability and regulatory support across multiple markets.

Flurazepam is a benzodiazepine that acts on the central nervous system to promote sleep.

Insomnia (sleep onset): reduces the time required to fall asleep. Insomnia (sleep maintenance): decreases the number of nocturnal awakenings. Insomnia (overall sleep quality): increases total sleep time and improves perceived sleep quality.

Flurazepam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness - Fatigue - Dizziness - Memory impairment - Ataxia - Headache

Serious or Rare Side Effects: - Respiratory depression - Severe allergic reaction (e.g., rash, angioedema) - Paradoxical agitation or aggression - Depression or suicidal thoughts - Dependence and withdrawal syndrome - Hepatic dysfunction

When prescribing or dispensing Flurazepam, consider the following safety measures. - Assess renal and hepatic function: adjust use in severe impairment. - Avoid abrupt discontinuation: taper under medical supervision to prevent withdrawal. - Use caution in elderly patients: increased sensitivity to sedation and falls. - Avoid concurrent CNS depressants: risk of enhanced sedation and respiratory depression. - Pregnancy and lactation: consult a healthcare provider before use. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Flurazepam can interact with several other medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Alcohol: additive central nervous system depression. - Opioids: increased risk of respiratory depression. - Other benzodiazepines: cumulative sedation and profound CNS depression.

Moderate Interactions (Monitor Closely): - SSRIs or other antidepressants: may increase sedation. - Antihistamines: additive drowsiness. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise flurazepam plasma concentrations.